A Phase II Study of Weekly Docetaxel and Topotecan in Patients With Platinum-Resistant, Recurrent Epithelial Ovarian Cancer.
Phase of Trial: Phase II
Latest Information Update: 04 Jun 2015
At a glance
- Drugs Docetaxel (Primary) ; Topotecan (Primary)
- Indications Fallopian tube cancer; Ovarian cancer; Peritoneal cancer
- Focus Therapeutic Use
- Acronyms Topo Txt
- 31 Aug 2018 Biomarkers information updated
- 13 Oct 2009 Actual end date (May 2008) added as reported by ClinicalTrials.gov.
- 13 Oct 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.